We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+3.59%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
–
AUM
$4.43B
AUM Growth
-$11.5M
Cap. Flow
+$137M
Cap. Flow %
3.08%
Top 10 Hldgs %
37.18%
Holding
3,745
New
225
Increased
1,516
Reduced
1,175
Closed
233

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$39.4M
2
JMBS icon
Janus Henderson Mortgage-Backed Securities ETF
JMBS
+$26.6M
3
CVBF icon
CVB Financial
CVBF
+$17.4M
4
AAPL icon
Apple
AAPL
+$16.9M
5
BINC icon
BlackRock Flexible Income ETF
BINC
+$15.6M

Top Sells

Rank Stock Value
1
PLTR icon
Palantir
PLTR
+$25.2M
2
IGEB icon
iShares Investment Grade Systematic Bond ETF
IGEB
+$18.5M
3
GOVT icon
iShares US Treasury Bond ETF
GOVT
+$6.13M
4
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$3.91M
5
SSNC icon
SS&C Technologies
SSNC
+$3.41M

Sector Composition

Rank Sector Weight
1 Technology 15.96%
2 Healthcare 9.75%
3 Financials 7.52%
4 Communication Services 4.86%
5 Consumer Discretionary 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EHAB
3476
DELISTED
Enhabit
EHAB
$9 ﹤0.01%
1
– –
AVTX icon
3477
Avalo Therapeutics
AVTX
$983M
$8 ﹤0.01%
1
– –
HLX icon
3478
Helix Energy Solutions
HLX
$1.41B
$8 ﹤0.01%
1
– –
ABVEW
3479
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
$7 ﹤0.01%
300
– –
AVAL icon
3480
Grupo Aval
AVAL
$6.01B
$6 ﹤0.01%
2
– –
KALA icon
3481
KALA BIO
KALA
$14.5M
– –
0
– –
ITDD icon
3482
iShares LifePath Target Date 2040 ETF
ITDD
$107M
– –
0
– –
ALZN icon
3483
Alzamend Neuro
ALZN
$6.56M
– –
0
– –
IMUX icon
3484
Immunic
IMUX
$195M
– –
0
– –
CUTR
3485
DELISTED
Cutera, Inc.
CUTR
$2 ﹤0.01%
150
– –
CCO icon
3486
Clear Channel Outdoor Holdings
CCO
$1.23B
$1 ﹤0.01%
1
– –
XXII
3487
22nd Century Group
XXII
$1.48M
– –
0
– –
NKLA
3488
DELISTED
Nikola Corporation Common Stock
NKLA
$1 ﹤0.01%
5
– –
AAXJ icon
3489
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.77B
– –
-36
Closed -$2.6K
ADV icon
3490
Advantage Solutions
ADV
$361M
– –
-3
Closed -$184
AHCO icon
3491
AdaptHealth
AHCO
$759M
– –
-63
Closed -$600
AKO.B icon
3492
Embotelladora Andina Series B
AKO.B
$4.95B
– –
-1
Closed -$18
OSG
3493
Octave Specialty Group
OSG
$222M
– –
-61
Closed -$772
AMCX icon
3494
AMC Global Media
AMCX
$489M
– –
-3,076
Closed -$30.5K
ANIP icon
3495
ANI Pharmaceuticals
ANIP
$1.78B
– –
-36
Closed -$1.99K
APGE icon
3496
Apogee Therapeutics
APGE
$10.2B
– –
-6
Closed -$272
ARAY icon
3497
Accuray
ARAY
$34M
– –
-40,000
Closed -$79.2K
ARKQ icon
3498
ARK Autonomous Technology & Robotics ETF
ARKQ
$2.1B
– –
-70
Closed -$5.41K
ATLC icon
3499
Atlanticus Holdings
ATLC
$1.52B
– –
-7
Closed -$390
AVAH icon
3500
Aveanna Healthcare
AVAH
$2.07B
– –
-20
Closed -$91
138 139
140
141 142

Similar funds

HFS
Hantz Financial Services Southfield, Michigan $6.56B AUM 16.11% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
LAM
Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return
BF
BOK Financial Tulsa, Oklahoma $6.54B AUM 25.41% 1-Year Est. Return
NMIMC
Northwestern Mutual Investment Management Company Milwaukee, Wisconsin $6.6B AUM 19.75% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Parallel Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Parallel Advisors held 3,745 positions worth $4.43B, down 0.26% from $4.45B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors deployed $137M of net new capital in Q1 2025, opening 225 new positions and adding to 1,516 existing holdings. Its largest new stake was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Palantir, an estimated $25.2M trimmed.

  • Parallel Advisors's largest Q1 2025 buy was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
  • Parallel Advisors added most to Microsoft in Q1 2025, an estimated $39.4M increase.
  • Parallel Advisors's biggest Q1 2025 reduction was Palantir, cutting an estimated $25.2M.
  • Parallel Advisors fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $2.68M.
  • Parallel Advisors's ten largest holdings make up 37% of its $4.43B portfolio in Q1 2025.
  • Parallel Advisors opened 225 new positions and closed 233 in Q1 2025.
  • Parallel Advisors's portfolio value fell 0.26% quarter-over-quarter to $4.43B.

Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.